ATLASATLAS fair value
A$1.67
Below fair value · 40% discount
Range: A$1.22–A$2.28Fair valuePrice
Bls Pharmaceuticals (BLS.AU)
Bls Pharmaceuticals share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Australian Securities Exchange · Australia
A$1.00▲ +5.26%
Prices as of Oct 27, 2026 · AUD
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Bls Pharmaceuticals in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Bls Pharmaceuticals
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Bls Pharmaceuticals's fair value at about A$1.67 per share (reasonable range: A$1.22 to A$2.28). At A$1.00, the stock trades 40% below it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Bls Pharmaceuticals a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between A$0.857 and A$1.12; in 9 out of 10, between A$0.674 and A$1.43. Estimated annual volatility is 60%.
Key numbers
- Market cap
- A$247M
- Market cap (USD)
- $173M
- P/E ratio
- 13.2
- Revenue (12 months)
- A$73.9M
- Gross margin
- 53.4%
- Operating margin
- 22.6%
- Net margin
- 20.8%
- Beta
- 0.55
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Bls Pharmaceuticals sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
On the business: net margin is 20.8%; it trades at 13.2 times earnings.
Its beta is 0.55: it tends to move less than the market.
About the company
BLS Pharmaceuticals Limited manufactures, imports, exports, and supplies controlled drugs and prescription medicines in Australia, the United Kingdom, Europe, and Japan. It operates through Manufacture/Sales Australia, Plant Based/UK/EU/JPN/AUS, and Wholesale PCC/USA segments.
Want to see everything about Bls Pharmaceuticals?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Bls Pharmaceuticals (BLS.AU) fair value?
About A$1.67 per share according to ATLAS (reasonable range: A$1.22 to A$2.28). With the stock at A$1.00, it is 40% below it.
What is the chance BLS.AU goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, BLS.AU ends the month between A$0.857 and A$1.12.
How big is Bls Pharmaceuticals and what is its P/E ratio?
Bls Pharmaceuticals's market capitalization is A$247M. Its price-to-earnings (P/E) ratio is 13.2: you pay A$13.2 for each A$1.00 of yearly earnings.
How volatile is BLS.AU?
ATLAS estimates annual volatility at 60%. In a typical month, half of the outcomes end between A$0.857 and A$1.12.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer